ABC transporters are intricately linked to cancer through their role in multidrug resistance (MDR). Cancer cells often overexpress certain ABC transporters, such as ABCB1 (P-glycoprotein), ABCC1 (MRP1), and ABCG2 (BCRP), which can pump out chemotherapeutic drugs, rendering treatments less effective.
